ArticleThoracic cancer2022

Chemoimmunotherapy versus immune checkpoint inhibitors monotherapy as first-line treatment for advanced non-small cell lung cancer.

Alessandro RizzoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.